InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
62,783.27
(
-0.17%
)
Post# of 111
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

shmoopy38

Send PM Follow Ignore
Followers 49
Posts 4907
Boards Moderated 1
Alias Born 01/05/2005

shmoopy38

Re: shmoopy38 post# 72

Friday, 04/25/2008 10:29:08 AM

Friday, April 25, 2008 10:29:08 AM

Post# of 111
Lonza settles legal dispute with Northwest Biotherapeutics on GS Gene products
04.24.08, 3:04 AM ET

FRANKFURT (Thomson Financial) - Lonza Group AG. said Northwest Biotherapeutics Inc. agreed to destroy the GS Gene Expression system materials, made by Lonza, in its possession to end a legal dispute.

The GS Gene Expression System, owned and licensed by Lonza, is used to make therapeutic recombinant proteins and monoclonal antibodies.

maria.sheahan@thomsonreuters.com

Copyright Thomson Financial News Limited 2008. All rights reserved.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up